Loading...
Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
INTRODUCTION: The integrase strand transfer inhibitor dolutegravir (DTG) has a high genetic barrier to resistance. Only rare cases of resistance to DTG have been reported when it is used as a component of antiretroviral therapy regimens in treatment-experienced patients unless there was prior use of...
Na minha lista:
| Udgivet i: | South Afr J HIV Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AOSIS
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7433307/ https://ncbi.nlm.nih.gov/pubmed/32832110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4102/sajhivmed.v21i1.1062 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|